当前位置: 首页 > 期刊 > 《健康大视野·医学分册》 > 2018年第22期
编号:13334149
布地奈德混悬液雾化吸入治疗成人肺炎支原体肺炎后慢性咳嗽的临床效果(1)
http://www.100md.com 2018年11月15日 《健康大视野》 2018年第22期
     【摘 要】目的:探讨布地奈德混悬液雾化吸入治疗成人肺炎支原体感染后慢性咳嗽的临床效果。方法:选取2015年6月至2018年6月于我院进行治疗的肺炎支原体肺炎后慢性咳嗽患者共计88例,根据患者的就诊时间将其分为观察组和对照组,对照组患者使用氨溴索注射液进行雾化吸入治疗,观察组患者则使用布地奈德混悬液进行雾化吸入治疗,对比两组患者的临床疗效。结果:观察组患者的临床咳嗽评分较之对照组要更低,观察组患者的临床治疗效果要好于对照组,差异具有统计学意义(p<0.05)。结论:在肺炎支原体肺炎感染后慢性咳嗽的治疗中,应用布地奈德混悬液雾化吸入治疗具有较好的临床疗效,值得推广使用。

    【关键词】布地奈德;肺炎支原体;肺炎;慢性咳嗽

    Clinical effect of nebulization inhalation of budesonideon chronic cough after Mycoplasma pneumoniae infection

    Abstract:Objective To investigate the clinical effect of nebulization inhalation of budesonide on chronic cough after Mycoplasma pneumoniae infection. Methods: 88 patients with chronic cough after Mycoplasma pneumoniae infection who were treated in our hospital from June 2015 to June 2018 were divided into observation group and control group according to their visiting time. The control group was treated with ambroxol injection and the observation group was treated with budesonide suspension. inhalation treatment ......
1 2 3下一页

您现在查看是摘要页,全文长 3543 字符